Source document or public record

FDA 510(k) K241806 — Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel

FDA 510(k) index record K241806. Device: Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel. Applicant as listed: Life Technologies Corporation. Decision date: 2025-01-08.

OtherU.S. Food and Drug Administration (FDA)2025-01-08

Source

"device_name": "Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K241806.

Device name: Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel. Applicant as listed: Life Technologies Corporation.

Decision date: 2025-01-08. Decision wording: Substantially Equivalent.

Product code: QOF. Regulation: 21 CFR 866.3981. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.